Journal article

Correction to Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways [Oncotarget, 6, 35, (2015), 38166-38180] DOI: 10.18632/oncotarget.6241

DW Greening, ST Lee, H Ji, RJ Simpson, A Rigopoulos, C Murone, C Fang, S Gong, G O'Keefe, AM Scott

Oncotarget | Published : 2016